Strata Skin Sciences (SSKN) Expected to Announce Earnings on Wednesday

Strata Skin Sciences (NASDAQ:SSKN) will likely be posting its Q2 2025 quarterly earnings results after the market closes on Wednesday, August 13th. Analysts expect Strata Skin Sciences to post earnings of ($0.27) per share and revenue of $8.56 million for the quarter.

Strata Skin Sciences (NASDAQ:SSKN) last announced its quarterly earnings data on Wednesday, May 14th. The medical device company reported ($0.58) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.56) by ($0.02). Strata Skin Sciences had a negative net margin of 27.22% and a negative return on equity of 138.22%. The firm had revenue of $6.81 million during the quarter, compared to the consensus estimate of $7.28 million. On average, analysts expect Strata Skin Sciences to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Strata Skin Sciences Trading Down 6.8%

Shares of Strata Skin Sciences stock opened at $1.78 on Monday. The stock’s 50-day simple moving average is $2.23 and its 200 day simple moving average is $2.51. Strata Skin Sciences has a 52-week low of $1.78 and a 52-week high of $3.79. The stock has a market capitalization of $7.42 million, a P/E ratio of -0.78 and a beta of 0.66. The company has a debt-to-equity ratio of 5.71, a quick ratio of 0.87 and a current ratio of 1.05.

Strata Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.